NASDAQ$GNPX
Genprex Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
GNPX Q1 2024 — $50.0M revenue
If the Company is not able to timely and successfully raise additional capital, the timing of its clinical trials, financial condition and results of operations may be materially and adversely affecte. Genprex Inc reported Q1 2024 results. Net income of $6.0M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $50.0M.
- Net income: $6.0M.
- Operating income: $6.0M.
Headline financials
Revenue & EPS history
Genprex · Revenue · Quarterly
$135
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
+1.3%
Avg return
Earnings day
-2.6%
Avg return
5 days after
-16.0%
Avg return
30 days after
46%
13 / 28 earnings
Positive
+39.3%
Q2 2022
Best reaction
-21.5%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | -3.0% | — | |
| Q4 2025 | +2.3% | -13.0% | -44.9% | |
| Q3 2025 | +7.0% | -19.3% | -31.4% | |
| Q2 2025 | -1.9% | -24.5% | +35.2% | |
| Q1 2025 | +2.2% | -10.5% | +13.4% | |
| Q4 2024 | +2.9% | -3.5% | -3.5% | |
| Q3 2024 | -21.5% | -34.9% | -44.5% | |
| Q2 2024 | -11.3% | -48.6% | -66.9% | |
| Q1 2024 | +5.0% | +6.7% | +1.3% | |
| Q4 2023 | -4.7% | +0.7% | -24.2% | |
| Q3 2023 | +13.5% | +7.9% | -2.6% | |
| Q2 2023 | -5.6% | -9.4% | -12.7% | |
| Q1 2023 | +1.4% | +14.8% | +1.9% | |
| Q4 2022 | -2.5% | -11.4% | -9.4% | |
| Q3 2022 | -2.9% | -7.9% | -16.5% | |
| Q2 2022 | +39.3% | +61.3% | +17.3% | |
| Q1 2022 | +14.4% | +10.6% | +7.6% | |
| Q4 2021 | -2.6% | -0.4% | -31.0% | |
| Q3 2021 | -4.8% | -15.9% | -37.2% | |
| Q2 2021 | -9.3% | -5.2% | +0.7% | |
| Q1 2021 | +6.6% | +12.7% | -99.9% | |
| Q4 2020 | -5.4% | -3.8% | -13.4% | |
| Q3 2020 | -0.6% | -0.3% | +3.5% | |
| Q2 2020 | -4.2% | +12.6% | -4.5% | |
| Q1 2019 | +0.0% | -2.2% | -24.4% | |
| Q3 2018 | -5.7% | -6.4% | -16.4% | |
| Q2 2018 | +2.8% | -2.1% | -21.7% | |
| Q1 2018 | +20.2% | +22.6% | -6.6% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro